Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents

Por Serkova, Natalie J., Eckhardt, S. Gail
Publicado no Front Oncol (2016)

Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers

Por Davis, S. Lindsey, Eckhardt, S. Gail, Tentler, John J., Diamond, Jennifer R.
Publicado em 2014

Accelerated Approval and Breakthrough Therapy Designation: Oncology Drug Development on Speed?

Por Yao, James C., Meric-Bernstam, Funda, Lee, J. Jack, Eckhardt, S. Gail
Publicado em 2013

Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models

Por Pitts, Todd M., Morrow, Mark, Kaufman, Sara A., Tentler, John J., Eckhardt, S. Gail
Publicado em 2009

From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development

Por Lieu, Christopher H., Tan, Aik-Choon, Leong, Stephen, Diamond, Jennifer R., Eckhardt, S. Gail
Publicado em 2013

The IGF-1R/IR Tyrosine Kinase Inhibitor, PQIP, Exhibits Enhanced Anti-Tumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models

Por Flanigan, Sara A., Pitts, Todd M., Eckhardt, S. Gail, Tentler, John J., Tan, Aik Choon, Thorburn, Andrew, Leong, Stephen
Publicado em 2010

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors

Por Plimack, Elizabeth R., LoRusso, Patricia M., McCoon, Patricia, Tang, Weifeng, Krebs, Annetta D., Curt, Gregory, Eckhardt, S. Gail
Publicado em 2013

Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma

Por Chen, Robert W., Bemis, Lynne T., Amato, Carol M., Myint, Han, Tran, Hung, Birks, Diane K., Eckhardt, S. Gail, Robinson, William A.
Publicado em 2008

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in pat...

Por Chow, Laura Q. M., Eckhardt, S. Gail, O’Bryant, Cindy L., Schultz, Mary Kay, Morrow, Mark, Grolnic, Stacy, Basche, Michele, Gore, Lia
Publicado em 2007

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines

Por Morelli, M. Pia, Brown, Amy M., Pitts, Todd M., Tentler, John J., Ciardiello, Fortunato, Ryan, Anderson, Jürgensmeier, Juliane M., Eckhardt, S. Gail
Publicado em 2009

Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells

Por Klawitter, Jelena, Kominsky, Douglas J, Brown, Jaimi L, Klawitter, Jost, Christians, Uwe, Leibfritz, Dieter, Melo, Junia V, Eckhardt, S Gail, Serkova, Natalie J
Publicado em 2009

Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials

Por Basche, Michele, Barón, Anna E., Eckhardt, S. Gail, Balducci, Lodovico, Persky, Martha, Levin, Adrah, Jackson, Nathaniel, Zeng, Chan, Vranas, Pamela, Steiner, John F.
Publicado em 2008

Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer

Por Eckhardt, S. Gail, De Porre, Peter, Smith, David, Maurel, Joan, Steward, William P., Bouche, Olivier, van de Velde, Helgi, Michiels, Bart, Bugat, Roland
Publicado em 2008

A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy

Por Lieu, Christopher, Chow, Laura, Pierson, A. Scott, Eckhardt, S. Gail, O'Bryant, Cindy L., Morrow, Mark, Tran, Zung Vu, Wright, John J., Gore, Lia
Publicado em 2008

A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors

Por Lam, Elaine T., O'Bryant, Cindy L., Basche, Michele, Gustafson, Daniel L., Serkova, Natalie, Baron, Anna, Holden, Scott N., Dancey, Janet, Eckhardt, S. Gail, Gore, Lia
Publicado em 2008

Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer

Por Arcaroli, John J., Touban, Basel M., Tan, Aik Choon, Varella-Garcia, Marileila, Powell, Rebecca W., Eckhardt, S. Gail, Elvin, Paul, Gao, Dexiang, Messersmith, Wells A.
Publicado em 2010

Patient-derived tumour xenografts as models for oncology drug development

Por Tentler, John J., Tan, Aik Choon, Weekes, Colin D., Jimeno, Antonio, Leong, Stephen, Pitts, Todd M., Arcaroli, John J., Messersmith, Wells A., Eckhardt, S. Gail
Publicado em 2012

Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer

Por Bradshaw-Pierce, Erica L., Pitts, Todd M., Kulikowski, Gillian, Selby, Heather, Merz, Andrea L., Gustafson, Daniel L., Serkova, Natalie J., Eckhardt, S. Gail, Weekes, Colin D.
Publicado em 2013

Distress among caregivers of phase I trial participants: a cross-sectional study

Por Kessler, Elizabeth R., Moss, Angela, Eckhardt, S. Gail, Laudenslager, Mark L., Kilbourn, Kristin, Mauss, Iris B., Bowles, Daniel W., Hecker, Sharon, Fairclough, Diane L., Kutner, Jean S.
Publicado no Support Care Cancer (2014)

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Por Gore, Lia, Rothenberg, Mace L., O'Bryant, Cindy L., Schultz, Mary Kay, Sandler, Alan B., Coffin, Denise, McCoy, Candice, Schott, Astrid, Scholz, Catherine, Eckhardt, S. Gail
Publicado em 2008